In our recent live satellite sessions (HIV-1 genotyping targeting integrase: Perspectives on antiretroviral drug resistance surveillance across Africa and COVID-19 across Africa: Combating the impact of emerging variants of SARS-CoV-2) at ASLM2021, your peers shared their experiences and latest approaches in testing technology and surveillance options for understanding the evolution of viral pathogens, including SARS-CoV-2 and HIV.

Explore the talks you may have missed by viewing the on-demand presentations to hear about HIV-1 genotyping targeting integrase, African laboratory experiences, and lessons learned after over a year combating COVID-19 and the impact of emerging SARS-CoV-2 variants.


Trends of HIV drug resistance in Kenya
Leonard Kingwara, BSc, MPH, PhD Genomic and Molecular Surveillance Lead, Department of National Laboratory Services



Evaluation of the new Thermo Fisher Scientific HIVDR kit covering PR-RT-INT HIV drug resistance regions
Prof. Chika Onwuamah, Chief Research Scientist and the Team Lead for the Population Genomics and Cancer (POPGEC) Group at our Centre for Human Virology and Genomics



Use of COVID-19 screening to prevent the spread of the virus (CSIR journey toward establishing a COVID-19 diagnostic laboratory)
Dr. Alex Alexandre, Head of the CSIR Diagnostic Laboratory & Acting Research Group for Array Tech



Real-time PCR-based genotyping of SARS-CoV-2 to identify variants of concern, Johannesburg, South Africa, 2021
Kathleen Subramoney, Medical Scientist, NHLS Charlotte Maxeke Johannesburg Academic Hospital


For Research Use Only. Not for use in diagnostic procedures.

Style Sheet for Global Design System
Style Sheet for Komodo Tabs